Neurocrine Biosciences | 자기 자본과 준비금

Equity Capital And Reserves 변화 날짜
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amgen USD 6.23B 1.42B 2023-12
Cytokinetics USD -386323000 52.48M 2023-12
Dynavax Technologies USD 622.07M 17.16M 2023-12
Gilead Sciences USD 22.75B 435M 2023-12
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Teva Pharmaceutical Industries USD 6.93B 122M 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Neurocrine Biosciences 자기 자본과 준비금 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - May 2024.